Fischer Medical Ventures Ltd.
•2026-08-21
PROS
- Working capital cycle has improved - days down from 1158 to 869
- Company maintains a comfortable, low leverage position
CONS
- Operating cash flow has been negative in recent years
- A large part of profit comes from other income (67.1% of PBT)
- Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -31.27x)
- Promoter holding has decreased over last 2 years: -12.8pp
- Company has a low return on equity of 1.7% over last 3 years
- Company has a low return on capital employed of 3.8%
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | ADANIENT | 2979.00 | 54.17 | 403273.96 | 0.04 | -1461.54 | -249.67 | 32923.98 | 49.92 | 13.30 | 15.57 |
| 2. | AEGISLOG | 1363.65 | 38.25 | 47864.12 | 0.64 | 544.84 | 210.70 | 2356.86 | 37.07 | 19.76 | 30.28 |
| 3. | PREMIERENE | 1008.00 | 27.48 | 45758.31 | 0.10 | 4719.18 | 1433.23 | 24625.94 | 1252.52 | 41.97 | 29.03 |
| 4. | CPPLUS | 3307.45 | 81.98 | 39127.28 | 0.05 | 142.20 | 332.51 | 1402.42 | 89.51 | 29.48 | 14.52 |
| 5. | REDINGTON | 334.90 | 15.39 | 26181.63 | 1.79 | 453.49 | 94.65 | 34922.47 | 34.57 | 18.96 | 2.03 |
| 6. | HONASA | 476.90 | 62.48 | 15548.09 | 0.63 | 90.45 | 118.87 | 755.95 | 27.00 | 8.99 | 14.58 |
| 7. | LLOYDSENT | 78.59 | 106.84 | 11997.17 | 0.19 | 109.98 | -55.77 | 563.03 | 70.15 | 12.84 | 18.07 |
| 8. | SGMART | 805.80 | 81.69 | 10155.92 | 0.00 | 455.80 | 1310.71 | 13085.70 | 1044.08 | 11.45 | 4.49 |
| 9. | MMTC | 62.10 | 20.82 | 9315.00 | 0.00 | 104.24 | 135.52 | 0.68 | -50.00 | 6.90 | -1423.53 |
| 10. | CELLO | 358.45 | 25.31 | 7917.62 | 0.42 | 73.40 | -8.99 | 526.72 | -0.43 | 17.15 | 18.80 |
| 11. | EBGNG | 588.80 | 47.13 | 6713.00 | 0.00 | 28.93 | 56.21 | 412.46 | 32.08 | 20.14 | 11.97 |
| 12. | FISCHER | 38.88 | 91.08 | 2716.49 | 0.00 | 3.79 | -24.30 | 81.92 | 249.34 | 1.13 | 13.73 |
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | 10 | 40 | 12 | 49 | 23 | 86 | 101 | 98 | 82 | |
| 18 | 10 | 39 | 11 | 47 | 19 | 70 | 80 | 97 | 76 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — |
| Other Income | 0 | 1 | 0 | 0 | 0 | 7 | 2 | 1 | 1 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 4 | 4 |
| Depreciation | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 3 | 0 | 0 | 0 | 2 | 10 | 17 | 21 | -2 | 8 | |
| Tax % | 6.18% | 237.50% | -21.05% | 168.00% | 26.04% | 50.84% | 19.48% | 9.18% | -216.00% | 51.60% |
| Net Profit | 0 | -0 | 0 | -3 | 1 | 5 | 14 | 19 | -7 | 4 |
| 1 | -0 | 0 | -0 | 0 | 0 | 2 | 0 | -0 | 0 | |
| Equity Capital | 54 | 54 | 54 | 54 | 64 | 65 | 65 | 65 | 65 | 65 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 54 | 54 | 54 | 54 | 64 | 65 | 65 | 65 | 65 | 65 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
- 21
- 18
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 3
- Tax %
- 6.18%
- Net Profit
- 0
- 1
- Equity Capital
- 54
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 54
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- 10
- 10
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 0
- Depreciation
- 0
- 0
- Tax %
- 237.50%
- Net Profit
- -0
- -0
- Equity Capital
- 54
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 54
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- 40
- 39
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 0
- Tax %
- -21.05%
- Net Profit
- 0
- 0
- Equity Capital
- 54
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 54
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- 12
- 11
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 1
- 0
- Tax %
- 168.00%
- Net Profit
- -3
- -0
- Equity Capital
- 54
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 54
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- 49
- 47
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 1
- 2
- Tax %
- 26.04%
- Net Profit
- 1
- 0
- Equity Capital
- 64
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 64
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- 23
- 19
- Operating Profit
- —
- OPM %
- —
- Other Income
- 7
- Interest
- 1
- Depreciation
- 1
- 10
- Tax %
- 50.84%
- Net Profit
- 5
- 0
- Equity Capital
- 65
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 65
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- 86
- 70
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 1
- Depreciation
- 1
- 17
- Tax %
- 19.48%
- Net Profit
- 14
- 2
- Equity Capital
- 65
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 65
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- 101
- 80
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 1
- Depreciation
- 1
- 21
- Tax %
- 9.18%
- Net Profit
- 19
- 0
- Equity Capital
- 65
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 65
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- 98
- 97
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 4
- Depreciation
- 1
- -2
- Tax %
- -216.00%
- Net Profit
- -7
- -0
- Equity Capital
- 65
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 65
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- 82
- 76
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 4
- Depreciation
- 1
- 8
- Tax %
- 51.60%
- Net Profit
- 4
- 0
- Equity Capital
- 65
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 65
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|
| 0 | 21 | 111 | 367 | |
| 0 | 19 | 107 | 322 | |
| Operating Profit | 0 | 2 | 5 | — |
| OPM % | 8 | 11 | 4 | — |
| Other Income | 0 | 1 | 1 | 6 |
| Interest | 0 | 0 | 0 | 9 |
| Depreciation | 0 | 0 | 2 | 4 |
| -0 | 2 | 2 | 44 | |
| Tax % | -2,708 | 13 | 46 | 32 |
| Net Profit | -0 | 2 | 1 | 30 |
| EPS | -2 | 0 | 0 | — |
| Dividend Payout % | 0 | 0 | 22 | — |
| Minority Interest | 0 | -0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | -0 |
| Adjusted EPS | -0 | 0 | 0 | — |
| Minority Interest | 0 | -0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | -0 |
| Adjusted EPS | -0 | 0 | 0 | — |
- 0
- 0
- Operating Profit
- 0
- OPM %
- 8
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- -0
- Tax %
- -2,708
- Net Profit
- -0
- EPS
- -2
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -0
- 21
- 19
- Operating Profit
- 2
- OPM %
- 11
- Other Income
- 1
- Interest
- 0
- Depreciation
- 0
- 2
- Tax %
- 13
- Net Profit
- 2
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- 0
- 111
- 107
- Operating Profit
- 5
- OPM %
- 4
- Other Income
- 1
- Interest
- 0
- Depreciation
- 2
- 2
- Tax %
- 46
- Net Profit
- 1
- EPS
- 0
- Dividend Payout %
- 22
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- 367
- 322
- Operating Profit
- —
- OPM %
- —
- Other Income
- 6
- Interest
- 9
- Depreciation
- 4
- 44
- Tax %
- 32
- Net Profit
- 30
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 0
- Share of Associates
- -0
- Adjusted EPS
- —
- Minority Interest
- 0
- Share of Associates
- -0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- -62%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 2%
- Last Year:
- 1%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| LIABILITIES | - | - | - |
| Equity Capital | 0 | 54 | 64 |
| -0 | 27 | 244 | |
| 0 | 0 | 60 | |
| Trade Payables | 0 | 2 | 21 |
| 0 | 4 | 69 | |
| Total Liabilities | 0 | 86 | 457 |
| ASSETS | - | - | - |
| 0 | 15 | 24 | |
| Capital Work in Progress | 0 | 0 | 1 |
| 0 | 1 | 11 | |
| 0 | 4 | 9 | |
| 0 | 23 | 76 | |
| Cash & Bank | 0 | 38 | 251 |
| 0 | 5 | 85 | |
| Total Assets | 0 | 86 | 457 |
| Total Debt | 1 | 0 | 60 |
| Net Working Capital | 0 | 67 | 263 |
| Contingent Liabilities | 0 | 0 | 0 |
| Book Value per Share | -15.47 | 15.00 | 48.17 |
| Face Value | 10.00 | 10.00 | 10.00 |
| Total Debt | 1 | 0 | 60 |
| Net Working Capital | 0 | 67 | 263 |
| Contingent Liabilities | 0 | 0 | 0 |
| Book Value per Share | -15.47 | 15.00 | 48.17 |
| Face Value | 10.00 | 10.00 | 10.00 |
- Equity Capital
- 0
- -0
- 0
- Trade Payables
- 0
- 0
- Total Liabilities
- 0
- 0
- Capital Work in Progress
- 0
- 0
- 0
- 0
- Cash & Bank
- 0
- 0
- Total Assets
- 0
- Total Debt
- 1
- Net Working Capital
- 0
- Contingent Liabilities
- 0
- Book Value per Share
- -15.47
- Face Value
- 10.00
- Total Debt
- 1
- Net Working Capital
- 0
- Contingent Liabilities
- 0
- Book Value per Share
- -15.47
- Face Value
- 10.00
- Equity Capital
- 54
- 27
- 0
- Trade Payables
- 2
- 4
- Total Liabilities
- 86
- 15
- Capital Work in Progress
- 0
- 1
- 4
- 23
- Cash & Bank
- 38
- 5
- Total Assets
- 86
- Total Debt
- 0
- Net Working Capital
- 67
- Contingent Liabilities
- 0
- Book Value per Share
- 15.00
- Face Value
- 10.00
- Total Debt
- 0
- Net Working Capital
- 67
- Contingent Liabilities
- 0
- Book Value per Share
- 15.00
- Face Value
- 10.00
- Equity Capital
- 64
- 244
- 60
- Trade Payables
- 21
- 69
- Total Liabilities
- 457
- 24
- Capital Work in Progress
- 1
- 11
- 9
- 76
- Cash & Bank
- 251
- 85
- Total Assets
- 457
- Total Debt
- 60
- Net Working Capital
- 263
- Contingent Liabilities
- 0
- Book Value per Share
- 48.17
- Face Value
- 10.00
- Total Debt
- 60
- Net Working Capital
- 263
- Contingent Liabilities
- 0
- Book Value per Share
- 48.17
- Face Value
- 10.00
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| 0 | -7 | -87 | |
| Cash from Investing | 0 | -31 | -125 |
| Cash from Financing | 0 | 37 | 315 |
| 0 | -2 | 103 | |
| Free Cash Flow | 0 | -23 | -99 |
| OCF / Net Profit | -0.00 | -4.00 | -71.81 |
| Cumulative 5-Year FCF | 0 | 0 | 0 |
| OCF / Net Profit | -0.00 | -4.00 | -71.81 |
| Cumulative 5-Year FCF | 0 | 0 | 0 |
- 0
- Cash from Investing
- 0
- Cash from Financing
- 0
- 0
- Free Cash Flow
- 0
- OCF / Net Profit
- -0.00
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -0.00
- Cumulative 5-Year FCF
- 0
- -7
- Cash from Investing
- -31
- Cash from Financing
- 37
- -2
- Free Cash Flow
- -23
- OCF / Net Profit
- -4.00
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -4.00
- Cumulative 5-Year FCF
- 0
- -87
- Cash from Investing
- -125
- Cash from Financing
- 315
- 103
- Free Cash Flow
- -99
- OCF / Net Profit
- -71.81
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -71.81
- Cumulative 5-Year FCF
- 0
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| PER SHARE | - | - | - |
| EPS (₹) | -2.12 | 0.26 | 0.23 |
| Book Value (₹) | -15.47 | 15.00 | 48.17 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.05 |
| Cash EPS (₹) | -0.21 | 0.04 | 0.04 |
| PROFITABILITY | - | - | - |
| Operating Margin % | 8.47% | 8.86% | 3.02% |
| Net Margin % | -20.33% | 8.76% | 1.09% |
| ROE % | 0.00% | 4.60% | 0.62% |
| ROCE % | 4.97% | 5.35% | 1.13% |
| -14.72% | 4.25% | 0.44% | |
| EFFICIENCY | - | - | - |
| Debtor Days | 347 | 200 | 163 |
| Inventory Days | 0 | 78 | 22 |
| Payable Days | 0 | 24 | 45 |
| 347 | 254 | 140 | |
| FINANCIAL HEALTH | - | - | - |
| Debt to Equity (x) | -2.15x | 0.00x | 0.20x |
| Interest Coverage (x) | 0.92x | 32.23x | 5.50x |
| 5.18x | 18.37x | 3.59x | |
| GROWTH | - | - | - |
| Revenue Growth % | 0.00% | 0.00% | 427.61% |
| Operating Profit Growth % | 0.00% | 0.00% | 104.82% |
| Net Profit Growth % | 0.00% | 5135.34% | -34.28% |
| 0.00% | 112.14% | -9.86% | |
| VALUATION | - | - | - |
| P/E (x) | 0.00x | 242.49x | 386.61x |
| P/B (x) | 0.00x | 41.65x | 18.64x |
| Dividend Yield % | 0.00% | 0.00% | 0.01% |
| 0.00x | 1399.44x | 1144.95x |
- EPS (₹)
- -2.12
- Book Value (₹)
- -15.47
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -0.21
- Operating Margin %
- 8.47%
- Net Margin %
- -20.33%
- ROE %
- 0.00%
- ROCE %
- 4.97%
- -14.72%
- Debtor Days
- 347
- Inventory Days
- 0
- Payable Days
- 0
- 347
- Debt to Equity (x)
- -2.15x
- Interest Coverage (x)
- 0.92x
- 5.18x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
- EPS (₹)
- 0.26
- Book Value (₹)
- 15.00
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.04
- Operating Margin %
- 8.86%
- Net Margin %
- 8.76%
- ROE %
- 4.60%
- ROCE %
- 5.35%
- 4.25%
- Debtor Days
- 200
- Inventory Days
- 78
- Payable Days
- 24
- 254
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 32.23x
- 18.37x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 5135.34%
- 112.14%
- P/E (x)
- 242.49x
- P/B (x)
- 41.65x
- Dividend Yield %
- 0.00%
- 1399.44x
- EPS (₹)
- 0.23
- Book Value (₹)
- 48.17
- Dividend per Share (₹)
- 0.05
- Cash EPS (₹)
- 0.04
- Operating Margin %
- 3.02%
- Net Margin %
- 1.09%
- ROE %
- 0.62%
- ROCE %
- 1.13%
- 0.44%
- Debtor Days
- 163
- Inventory Days
- 22
- Payable Days
- 45
- 140
- Debt to Equity (x)
- 0.20x
- Interest Coverage (x)
- 5.50x
- 3.59x
- Revenue Growth %
- 427.61%
- Operating Profit Growth %
- 104.82%
- Net Profit Growth %
- -34.28%
- -9.86%
- P/E (x)
- 386.61x
- P/B (x)
- 18.64x
- Dividend Yield %
- 0.01%
- 1144.95x
Documents
Announcements
- General Updates
2026-08-17 - Fischer Medical Ventures Limited has informed the Exchange on the allotment of Equity shares pursuant to conversion of warrants
- Resignation of Director/KMP/SMP
2026-08-15 - Fischer Medical Ventures Limited has informed the Exchange about Resignation of Director/KMP/SMP
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
Nov 2025
Dec 2024

